OTC rs281865552: Understanding Ornithine Transcarbamylase Deficiency
The variant rs281865552 is located within the OTC gene, which provides instructions for an enzyme critical to the body's urea cycle. This variant is associated with ornithine transcarbamylase (OTC) deficiency, a rare genetic condition that can lead to the dangerous accumulation of ammonia in the blood.
What each genotype means
Typical OTC gene profile
This genotype represents the reference sequence for this position in the OTC gene. Individuals with this profile do not carry the specific variant associated with the pathogenic changes documented for this site.
This is the most common genotype observed in the general population.
Pathogenic variant carrier
This genotype indicates the presence of a variant that has been classified as pathogenic in clinical databases. Because the OTC gene is located on the X chromosome, this variant may be associated with ornithine transcarbamylase deficiency, a condition that can lead to ammonia accumulation; clinical significance depends on sex and individual health history.
This genotype is rare and is typically identified through clinical testing or cascade screening.
Pathogenic variant carrier
This genotype indicates the presence of a variant that has been classified as pathogenic in clinical databases. Because the OTC gene is located on the X chromosome, this variant may be associated with ornithine transcarbamylase deficiency, a condition that can lead to ammonia accumulation; clinical significance depends on sex and individual health history.
This genotype is rare and is typically identified through clinical testing or cascade screening.
What is the rs281865552 Variant?
The variant rs281865552 is a specific change in the DNA sequence of the OTC gene. In genomics, a variant represents a difference in the genetic code compared to the most common sequence found in the human population. This particular variant is categorized as a marker for carrier status, meaning it is studied for its potential to impact the function of the ornithine transcarbamylase enzyme. Because the OTC gene is located on the X chromosome, the inheritance pattern of variants within this gene is X-linked. This means that the impact of the variant can differ significantly between males, who have one X chromosome, and females, who have two. Understanding where this variant sits on the gene helps researchers determine how it might disrupt the production or the shape of the resulting protein, which is essential for maintaining healthy nitrogen levels in the body.
The Role of the OTC Gene
The OTC gene is responsible for producing the enzyme ornithine transcarbamylase. This enzyme plays a vital role in the urea cycle, a series of chemical reactions that occur primarily in the liver. The main purpose of the urea cycle is to process excess nitrogen, which is a byproduct of the body breaking down proteins. Under normal conditions, the urea cycle converts this nitrogen into urea, a compound that is safely excreted by the kidneys. When the OTC gene contains a variant that prevents the enzyme from functioning correctly, the urea cycle is interrupted. This leads to the accumulation of ammonia, a substance that is toxic to the body, particularly the nervous system. Because the urea cycle is essential for detoxification, any significant disruption in the OTC enzyme's ability to function can lead to serious health challenges.
Research and Clinical Associations
Research into the OTC gene has identified hundreds of variants associated with ornithine transcarbamylase deficiency. The evidence linking specific variants to this condition is often strong, as clinical studies have documented how these genetic changes correlate with the severity of hyperammonemia. In individuals with OTC deficiency, the enzyme may be missing, misshapen, or produced in insufficient quantities. Clinical outcomes vary widely; some individuals may experience severe symptoms shortly after birth, while others may have milder, later-onset symptoms. Because this is an X-linked disorder, females with one altered copy of the gene may show a range of symptoms due to a process called X-inactivation, where one X chromosome is turned off in each cell. It is important to note that the presence of a variant does not always guarantee a specific clinical outcome, and researchers continue to study how different mutations influence the severity of the condition.
Population Frequency and Interpretation
The variant rs281865552 is considered rare in the general population. Genetic databases track the frequency of such variants across different ancestral groups to help clinicians understand their prevalence. Because it is rare, most people will not carry this specific variant. When interpreting genetic information, it is crucial to remember that a variant's presence is only one piece of a larger clinical picture. Genetic testing results should always be discussed with a qualified healthcare provider or a genetic counselor who can provide context based on an individual's family history and clinical symptoms. This information is for educational purposes and should not be used to diagnose or treat any medical condition. If you have concerns about your genetic status or potential symptoms related to urea cycle disorders, please consult with a medical professional for appropriate testing and guidance.
How common is this variant?
The rs281865552 variant is classified as rare across global populations, meaning it is found in a very small percentage of individuals.
Frequently asked questions
What is OTC deficiency?
OTC deficiency is a rare, X-linked genetic disorder that prevents the body from properly breaking down ammonia. This leads to the accumulation of toxic ammonia in the blood, which can cause neurological issues.
How is OTC deficiency inherited?
It is an X-linked disorder, meaning the gene is located on the X chromosome. Males are typically more severely affected because they only have one X chromosome, while females may have variable symptoms.
Can I be a carrier of an OTC variant?
Yes, females can be carriers of an OTC variant. Because of X-inactivation, some carriers may experience mild symptoms, while others may remain asymptomatic.
What should I do if I have this variant?
If you have concerns about a genetic variant, you should consult with a healthcare provider or a genetic counselor. They can help interpret your results in the context of your personal and family health history.
Sources & further reading
Educational information only, last refreshed 9/17/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs281865552?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29